Hengeler Mueller advises Armira on the acquisition of a participation in the community of heirs of Horst Walter Sartorius

LifeScience Holding SCSp ("LSH"), a long-term oriented investor consortium led by investment holding Armira, has successfully completed the acquisition of a participation of approx. 40% in the Horst Walter Sartorius community of heirs from members of the Sartorius family. In total, the inheritances of the community of heirs comprise 50.09% of the ordinary shares of Dax listed Sartorius Aktiengesellschaft. Unaffected by the transaction, all shares held by the community of heirs continue to be subject to the execution of the will by an executor until mid-2028. In a separate, parallel transaction, Karin Sartorius-Herbst, the eldest daughter of testator Horst Sartorius, increased her existing stake within the community of heirs.

Hengeler Mueller advised Armira and LSH on the transaction. The team was led by partners Hans-Jörg Ziegenhain (M&A) and Daniel Illhardt (Corporate/Capital Markets) and included partners Daniel Möritz (M&A), Simon Patrick Link (Corporate/Capital Markets), Markus Ernst (Tax), Sarah Milde (Merger Control) (all Munich), Christian Wentrup (Inheritance Law/Corporate, Düsseldorf) and Daniela Böning (Financing, Frankfurt), counsel Anja Balitzki (Merger Control, Düsseldorf) as well as associates Johannes Ahlswede, Sara Dietz, Christian Hess (all Munich), Tobias Begemann (Berlin) (all Corporate/M&A), Moritz Evertz (Corporate), Carsten Bormann (Foreign Investment Control) (both Düsseldorf), Verena Klosterkemper and Carina Kämpf (both Tax, Munich).